Subtype
Lactotroph Pituitary Neuroendocrine Tumor
CI-CAN-00007941Explore in graph →
Non-malignant2 active trials
Loading cancer entity…
Subtype
CI-CAN-00007941Explore in graph →
Clinical trials
22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03038308 | Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole | completed | Phase 1 / Phase 2 | 16 | Columbia UniversityOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05236829 | Exercise Capacity and Physical Activity Level in Prolactinoma Patients | completed | — | 38 | Hacettepe UniversityOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT00939523 | Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy | completed | Phase 2 | 9 | Cedars-Sinai Medical CenterOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT01504399 | Rhinological Outcomes in Endonasal Pituitary Surgery |
Data updated 22 days agoSource updated Jun 4, 2024source: clinicaltrials
| completed |
| — |
| 235 |
| St. Joseph's Hospital and Medical Center, PhoenixOTHER |
| 1 |
| Aug 22, 2018 |
| clinicaltrials |
| NCT01620138 | Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas | completed | Phase 2 / Phase 3 | 21 | Universidade Federal do Rio de JaneiroOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT00697814 | Clomiphene in Males With Prolactinomas and Persistent Hypogonadism | completed | Phase 2 | 15 | Federal University of São PauloOTHER | 1 | Jun 16, 2008 | clinicaltrials |
| NCT00460616 | Cardiac Valve Complications in Prolactinomas Treated With Cabergoline(ValveCab) | completed | — | 50 | Federico II UniversityOTHER | 1 | Apr 16, 2008 | clinicaltrials |
| NCT00481299 | Insulin Resistance in Women With Prolactinoma | completed | — | 2,004 | Universidade Federal do Rio de JaneiroOTHER | 1 | Jun 1, 2007 | clinicaltrials |